Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.


Displaying records 1 through 3 (3 total).

Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y, Quinn M, Sankaranarayanan R, Sasieni P, Schmeler KM, Shastri SS. 2016. Secondary prevention of cervical cancer: American Society of Clinical Oncology resource-staffed clinical practice guidelines. Journal of Global Oncology [published online before print October 28, 2016],

Annotation: This guideline offers guidance on secondary prevention of cervical cancer. Contents include key recommendations for screening; triage; and treatment of women with precursor lesions. Recommendations for special populations, such as women who are HIV positive, immunosuppressed, pregnant, postpartum, or women who have had hysterectomies are also addressed. Topics include developing infrastructure for HPV testing, diagnosis, and treatment in settings without current mass screening; cost and policy implications, guideline implementation, and future directions.

Contact: American Society of Clinical Oncology, 2318 Mill Road, Suite 800, Alexandria, VA 22314, Telephone: (571) 483-1300 Fax: (703) 299-1044 E-mail: [email protected] Web Site: http://www.asco.org Available from the website.

Keywords: Advocacy, Cervical cancer, DNA testing, Diagnosis, Disease prevention, Human papillomavirus, International health, Medical treatment, Oral cancer, Oral health, Postpartum women, Pregnant women, Primary care, Triage, Women', s health

U.S. Congress, Office of Technology Assessment. 1992. Cystic fibrosis and DNA tests: Implications of carrier screening. Washington, DC: U.S. Congress, Office of Technology Assessment, 301 pp.

Annotation: This report examines the scientific, clinical, legal, economic, and social considerations of widespread carrier screening for cystic fibrosis. Specific topics covered include medical aspects, the state of the art in genetics, quality assurance, education and counseling, financing, discrimination issues, costs and cost-effectiveness, and CF carrier screening in the United Kingdom. Appendices discuss the epidemiology of mutations for cystic fibrosis and cases studies of other carrier screening programs.

Contact: U.S. Government Publishing Office, 732 North Capitol Street, N.W., Washington, DC 20401, Telephone: (202) 512-1800 Secondary Telephone: (866) 512-1800 Fax: (202) 512-2104 E-mail: [email protected] Web Site: http://www.gpo.gov Available from the website. Document Number: OTA-BA-532.

Keywords: Bioethics, Carrier state, Cystic fibrosis, DNA, Genetic screening, Screening

Texas Department of Health, Texas Genetics Network. 1992. Directory of genetic service providers. Austin, TX: Texas Department of Health, 89 pp.

Annotation: This directory lists genetic service providers in Texas. It is organized by category of service including medical genetics programs, biochemical genetics laboratories, cytogenetics laboratories, DNA laboratories, and sickle cell anemia programs. Each entry includes the program name, address, phone, program director, contact person, and a list of the clinical services provided. Many of the entries include information about cost reimbursement. [Funded by the Maternal and Child Health Bureau]

Contact: Texas Department of State Health Services, Children with Special Health Care Needs Services Program, MC 1938, PO Box 149347, Austin, TX 78714, Telephone: (512) 458-7355 Secondary Telephone: (800) 252-8023 Fax: (512) 458-7417 Web Site: http://www.dshs.state.tx.us/cshcn/default.shtm Available in libraries.

Keywords: DNA, Directories, Family support services, Genetic counseling, Genetic screening, Prenatal diagnosis, Sickle cell disease, Special health care needs

   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.